ELA-14 negative control

CSCC[C@@H](C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2CCC[C@H]2C(N[C@H](C(N3CCC[C@H]3C(O)=O)=O)CC4=CC=CC=C4)=O)=O)C(C)C)=O)C)=O)CO)=O)CC5=CNC=N5)=O)CC(C)C)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]6CCC(N6)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CS)=O

[1]Murza A, et, al. Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions. J Med Chem. 2016 Apr 14;59 (7) :2962-72.